In summary, overexpression of SETD5 in colon cancer cells induces the expression of CSC marker genes, resulting in the gain of stem cell-like properties in colorectal cancer cells, such as increased survival rates and tumor-initiating ability, and the promotion of RNA Pol II O-GlcNAcylation. The gene discussed is SETD5; the disease is colonic neoplasm.